Brief: Clovis Oncology Announces 2020 Operating Results
23/02/2021 13:05
Feb 23 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES 2020 OPERATING RESULTS
* Q4 LOSS PER SHARE $1.02
* Q4 EARNINGS PER SHARE ESTIMATE $-0.77 -- REFINITIV IBES
DATA
* $240.2 MILLION IN CASH AND CASH EQUIVALENTS AT DEC. 31,
2020,
ANTICIPATED TO FUND OPERATING PLAN INTO EARLY 2023
* QTRLY PRODUCT REVENUE $43.3 MILLION VERSUS $39.3 MILLION
Source text for Eikon: ID:nBw7HWqqwa
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber